7 completed, 4 terminated, 3 active not recruiting, 1 recruiting. 17 Phase 2, 3 Phase 1, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 17 | Completed 7, Terminated 4, Active not recruiting 3, Recruiting 1, Suspended 1, Unknown 1 |
| Phase 1 | 3 | Completed 1, Suspended 1, Terminated 1 |
| Phase 3 | 2 | Terminated 1, Unknown 1 |
Follow Cozaar: new trials by email Literature Review of Cozaar trials Research Report on Cozaar
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| FOLFIRINOX + Elraglusib + Losartan In Pancreatic Cancer FOLFIRNINOX, Losartan, 9-ING-41 - Pancreatic Adenocarcinoma, Pancreatic Adenocarcinoma Metastatic | Phase 2 | Active not recruiting | Colin D. Weekes, M.D., PhD | 70 | 2022-03-21 | 2026-09-11 |
| NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer Capecitabine, Fluorouracil, Irinotecan Hydrochloride - Pancreatic Adenocarcinoma, Stage 0 Pancreatic Cancer American Joint Committee on Cancer v8 | Phase 2 | Active not recruiting | OHSU Knight Cancer Institute | 42 | 2021-05-27 | 2026-01-14 |
| Losartan for Patients With COVID-19 Requiring Hospitalization Losartan, Placebo - Corona Virus Infection, Acute Respiratory Distress Syndrome | Phase 2 | Completed | University of Minnesota | 205 | 2020-04-13 | 2022-06-29 |
| Losartan for Patients With COVID-19 Not Requiring Hospitalization Losartan, Placebo - Corona Virus Infection, Acute Respiratory Distress Syndrome | Phase 2 | Completed | University of Minnesota | 117 | 2020-04-09 | 2022-05-04 |
| COVID MED Trial - Comparison Of Therapeutics for Hospitalized Patients Infected With COVID-19 Losartan, Placebo - SARS-CoV-2 Infection | Phase 2 / Phase 3 | Terminated | Bassett Healthcare | 15 | 2020-04-06 | 2022-03-24 |
| Chinese Medicine Treat for Hypertensive Renal Injury Losartan 100Mg Tab, Qianyangyuyin 20g Granule, placebo - Hypertension, Renal Injury | Phase 2 / Phase 3 | Unknown | Jiangsu Province Hospital of Traditional Chinese Medicine | 520 | 2019-09-10 | 2019-09-06 |
| Losartan and Inflammation in Cystic Fibrosis Losartan, placebo - Cystic Fibrosis | Phase 2 | Terminated | University of Miami | 7 | 2017-11-11 | 2020-11-27 |
| Pilot Trial: the Safety and Feasibility of Losartan for Pulmonary Vein Stenosis Losartan - Pulmonary Vein Stenosis, Children | Phase 1 / Phase 2 | Suspended | The Hospital for Sick Children | 40 | 2016-05-01 | 2019-07-30 |
| The ENRGISE (ENabling Reduction of Low-Grade Inflammation in SEniors) Pilot Study Omega-3 fish oil, Losartan, Corn Oil (Fish oil Placebo) - Inflammation | Phase 2 | Completed | University of Florida | 289 | 2016-04-26 | 2024-05-07 |
| Role of Sympathetic Overactivity and Angiotensin II in PTSD and CV Microneurography, Combat virtual reality video clip, Handgrip Exercise - Stress Disorders, Post-Traumatic | Phase 2 | Recruiting | Emory University | 134 | 2015-10-01 | 2026-05-18 |
| Reversing Tissue Fibrosis to Improve Immune Reconstitution in HIV Losartan, Placebo - HIV Infection, HIV Infections | Phase 2 | Completed | University of Minnesota | 52 | 2014-09-01 | 2020-12-11 |
| Study of Losartan in the Treatment of NAFLD in Children Losartan - NAFLD | Phase 2 | Completed | Miriam Vos, MD | 12 | 2013-07-01 | 2017-05-15 |
| Pilot Study of Losartan and N-acetylcysteine as Inhibitors of Muscle Oxidative Stress in Elderly N-acetylcysteine, Losartan, Placebo losartan - Aging | Phase 1 / Phase 2 | Completed | The University of Texas Medical Branch, Galveston | 6 | 2011-07-01 | 2018-05-08 |
| Hearing Outcomes Using Fractionated Proton Radiation Therapy for Vestibular Schwannoma Fractionated proton radiation, Losartan - Vestibular Schwannoma, Acoustic Neuroma | Phase 2 | Active not recruiting | Massachusetts General Hospital | 30 | 2011-03-08 | 2026-09-11 |
| Benazepril Hydrochloride, Lisinopril, Ramipril, or Losartan Potassium in Treating Hypertension in Patients With Solid Tumors lisinopril, losartan potassium, laboratory biomarker analysis - Hypertension, Unspecified Adult Solid Tumor, Protocol Specific | Phase 2 | Terminated | Wake Forest University Health Sciences | 6 | 2011-02-01 | 2018-08-28 |
| Pilot Study of a Multi-Drug Regimen for Severe Pulmonary Fibrosis in Hermansky-Pudlak Syndrome Losartan, Zileuton, N-Acetylcysteine - Hermansky-Pudlak Syndrome (HPS), Pulmonary Fibrosis | Phase 1 / Phase 2 | Terminated | National Human Genome Research Institute (NHGRI) | 3 | 2007-04-01 | 2013-08-02 |
| Effect of Losartan in Patients With Nonobstructive Hypertrophic Cardiomyopathy losartan, placebo - Hypertrophic Cardiomyopathy | Phase 2 | Completed | Massachusetts General Hospital | 20 | 2007-02-01 | 2013-09-05 |
COVID-19 (3) · Coronavirus Infections (3) · Hypertension (2) · Respiratory Distress Syndrome (2) · Severe Acute Respiratory Syndrome (2) · Albinism (1) · Albinism, Oculocutaneous (1) · Cardiomyopathy, Hypertrophic (1) · Cystic Fibrosis (1) · Fibrosis (1) · HIV Infections (1) · Hermanski-Pudlak Syndrome (1) · Infections (1) · Inflammation (1) · Lung Diseases (1)
University of Minnesota (3) · Massachusetts General Hospital (2) · Bassett Healthcare (1) · Colin D. Weekes, M.D., PhD (1) · Emory University (1) · Jiangsu Province Hospital of Traditional Chinese Medicine (1) · Miriam Vos, MD (1) · National Human Genome Research Institute (NHGRI) (1) · OHSU Knight Cancer Institute (1) · The Hospital for Sick Children (1) · The University of Texas Medical Branch, Galveston (1) · University of Florida (1) · University of Miami (1) · Wake Forest University Health Sciences (1)
United States (15) · Canada (1)
Christopher Tignanelli, MD (2) · Michael Puskarich, MD, MS (2) · Astrid M Horstman, PhD (1) · Charles D Lopez (1) · Christopher A Caldarone, MD (1) · Colin D Weekes, MD, PhD (1) · Daniel Freilich, MD (1) · Helen A. Shih, MD (1) · Jeanie Park, MD (1) · Marco Pahor, MD (1) · Matthias Salathe, MD (1) · Melinda Sheffield-Moore, PhD (1) · Michael A Fifer, MD (1) · Ming Liu (1) · Miriam Vos, MD, MSPH (1)
PMID 32658300, PMID 24621999, PMID 29992039, PMID 30541065, PMID 34195577, PMID 34473343, PMID 35229827, PMID 35294537
R03DK096157 (1), U01AG050499 (1), U01AI105872 (1)